Vion Pharmaceuticals vionpharm.com


Public lists: Pharma Startups (4743)

Vion Pharmaceuticals is a Healthcare/Biotechnology company based in New Haven, Connecticut. Vion Pharmaceuticals' investors include Langley Capital, TCMP3 Capital, Silver Oak Investments, Rodman & Renshaw, Highbridge Capital Management, Gamma Capital Partners, Rock Hill Investment Management, Bristol Capital Advisors, Platinum Management, Atlas Assets, Lonestar Partners, Xmark Asset Management, Cohanzick Management, Cowen Group and Riverview Group.

Vion Pharmaceuticals is a Healthcare/Biotechnology company based in New Haven, Connecticut. Vion Pharmaceuticals' investors include Langley Capital, TCMP3 Capital, Silver Oak Investments, Rodman & Renshaw, Highbridge Capital Management, Gamma Capital...Show all

Company (Dead / Inactive)

Phone: 203-498-4210

Fax:

4 Science Park

New Haven, 06511
Connecticut, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Vion Pharmaceuticals $86.7M Dec 18, 2009

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Vion Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
AllianzCorporationMunich, GermanyUnattributed VC, Unattributed VC - II
Bristol Capital AdvisorsAsset/Investment ManagementLos Angeles, California, United StatesUnattributed VC - III
CowenInvestment BankNew York, New York, United StatesUnattributed VC - III
Cohanzick ManagementUnattributed VC - III
Atlas AssetsUnattributed VC - III
See all 19 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Combination therapy comprising cloretazine Mar 25, 2005 Oct 20, 2009 Patent
Genetically modified tumor-targeted bacteria with reduced virulence Apr 28, 2005 Apr 07, 2009 Patent